SCHLAGWORTE: Impact Life Sciences
All-in-one solution on offer
The medical technology company Luma Vision specialises in interventional cardiology procedures, offering cutting-edge hardware, software, and data science solutions for the treatment of cardiac...
‘A dating app for transplants’
Pirche develops AI-powered tools that personalise immunosuppression in transplantation medicine. Managing Director Tobias Klein explains how the platform is gaining clinical traction, why crowdfunding...
Biopesticides driving progress
Increasing resistance among pests and mounting regulatory requirements are placing growing pressure on agriculture. SenseUP Biotechnology offers an innovative, effective, and, above all, affordable...
Crowdfunding in the life sciences
Crowdfunding is a method of raising money to finance projects by collecting small contributions from a large number of people, typically via online platforms....
Patient communication is more than just bedside manners
Good healthcare has always relied on precise communication. But what happens when patients don’t understand the language spoken by the medical staff? In a...
Next-generation therapies
Ningaloo Biosystems’ technology enables the control of biological processes in living cells using light, thereby improving the productivity, quality, scalability, and reliability of pharmaceutical...
How big pharma companies rethink – and what start-ups can learn...
The patent cliff signifies the expiry of patent protection for major drugs, causing revenue drops as generics enter the market. Pharma companies face challenges...
Legal pathways through the valley of death
A major challenge for companies in life sciences is to live through the long years of turning innovation into clinical studies and subsequently into...
Biotech boom in Switzerland
The biotech sector is powering a strong first half year for the Swiss venture capital market. With CHF 705 million in invested capital, the...
Europe invests billions – but where are the scaled start-ups?
European countries, especially Germany, invest billions annually in basic and translational research. The scientific quality is high, the researchers are world-class, and the infrastructure...
German biotechnology needs a tailwind
Biotechnology is one of the most promising key industries – with the potential to achieve medical breakthroughs, establish new production processes and shape a...
Heading for clinical breakthrough backed by a broad investor base
Tubulis wants to improve the efficacy of cancer therapies by using antibody drug conjugates (ADCs). Three pipeline products are currently in clinical development. ‘We...
Europe’s shot at radiopharmaceutical leadership
The radiopharmaceutical industry is entering a new era. Driven by clinical breakthroughs, regulatory momentum, and investor confidence, this once-niche field is now positioned to...
‘Be patient, but persistent!’
Ghazaleh Madani, CEO of the biotech start-up CanChip, which was founded in 2023, says she is on a mission to revolutionise cancer research with...
Building microbial consortia
mbiomics, based in Neuried near Munich, is pursuing an innovative ‘microbiome engineering’ approach. The company leverages state-of-the-art analytical techniques to precisely develop bacterial consortia...